Homocysteine‐potentiated Kelch‐like ECH‐associated protein 1 promotes senescence of neuroblastoma 2a cells via inhibiting ubiquitination of β‐catenin

Abstract

AbstractElevated serum homocysteine (Hcy) level is a risk factor for Alzheimer's disease (AD) and accelerates cell aging. However, the mechanism by which Hcy induces neuronal senescence remains largely unknown. In this study, we observed that Hcy significantly promoted senescence in neuroblastoma 2a (N2a) cells with elevated β‐catenin and Kelch‐like ECH‐associated protein 1 (KEAP1) levels. Intriguingly, Hcy promoted the interaction between KEAP1 and the Wilms tumor gene on the X chromosome (WTX) while hampering the β‐catenin‐WTX interaction. Mechanistically, Hcy attenuated the methylation level of the KEAP1 promoter CpG island and activated KEAP1 transcription. However, a slow degradation rate rather than transcriptional activation contributed to the high level of β‐catenin. Hcy‐upregulated KEAP1 competed with β‐catenin to bind to WTX. Knockdown of both β‐catenin and KEAP1 attenuated Hcy‐induced senescence in N2a cells. Our data highlight a crucial role of the KEAP1‐β‐catenin pathway in Hcy‐induced neuronal‐like senescence and uncover a promising target for AD treatment.